• LAST PRICE
    22.1800
  • TODAY'S CHANGE (%)
    Trending Up0.3400 (1.5568%)
  • Bid / Lots
    22.2000/ 1
  • Ask / Lots
    23.6000/ 1
  • Open / Previous Close
    21.8900 / 21.8400
  • Day Range
    Low 21.3600
    High 22.2200
  • 52 Week Range
    Low 11.2500
    High 58.3800
  • Volume
    866,406
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 21.84
TimeVolumeAKRO
09:32 ET649621.785
09:36 ET10021.85
09:39 ET42121.83
09:41 ET172421.76
09:43 ET30021.87
09:45 ET270221.89
09:48 ET32521.855
09:50 ET10021.885
09:54 ET14021.95
09:56 ET10021.82
09:57 ET120021.89
09:59 ET60021.79
10:01 ET30021.74
10:03 ET50021.72
10:06 ET409021.81
10:12 ET14321.85
10:14 ET40021.9
10:15 ET187521.775
10:17 ET30021.75
10:19 ET61321.85
10:21 ET30021.75
10:24 ET110021.71
10:26 ET20021.73
10:28 ET55221.69
10:30 ET10021.675
10:32 ET10021.7
10:33 ET110021.725
10:35 ET330021.75
10:37 ET30021.74
10:39 ET10021.755
10:42 ET20021.74
10:46 ET276321.83
10:50 ET60021.79
10:51 ET30021.8
10:53 ET40021.81
10:55 ET10021.83
10:57 ET10021.81
11:00 ET269621.795
11:02 ET100021.825
11:04 ET405221.79
11:06 ET50021.76
11:11 ET115721.71
11:13 ET151621.7
11:15 ET91921.68
11:18 ET80021.755
11:20 ET110021.695
11:22 ET20021.71
11:24 ET10021.69
11:27 ET30021.71
11:29 ET58921.72
11:31 ET160021.62
11:33 ET601521.685
11:36 ET20021.685
11:38 ET176021.65
11:40 ET120021.65
11:42 ET20021.69
11:47 ET130021.695
11:51 ET43721.65
11:54 ET164021.61
12:00 ET10021.59
12:02 ET20021.59
12:03 ET15021.59
12:05 ET587421.66
12:07 ET40021.68
12:09 ET336921.67
12:12 ET211321.61
12:14 ET80021.63
12:16 ET30821.61
12:18 ET80021.63
12:20 ET83721.58
12:21 ET119421.63
12:25 ET20021.635
12:27 ET120021.65
12:32 ET30621.61
12:34 ET460421.6
12:36 ET56321.595
12:38 ET30021.605
12:39 ET60021.63
12:41 ET131621.61
12:43 ET110021.61
12:45 ET409821.635
12:48 ET10021.64
12:50 ET10021.66
12:52 ET30021.645
12:54 ET70021.5982
12:57 ET164221.56
12:59 ET30021.56
01:01 ET30021.595
01:03 ET210121.59
01:06 ET150021.59
01:08 ET20021.615
01:15 ET39421.64
01:17 ET20021.595
01:19 ET10021.64
01:24 ET295521.63
01:26 ET135021.58
01:30 ET316521.58
01:32 ET30021.585
01:33 ET532421.57
01:35 ET658621.535
01:37 ET968421.5
01:39 ET92421.515
01:42 ET771221.39
01:44 ET284321.47
01:46 ET10021.465
01:48 ET120021.53
01:50 ET122521.55
01:51 ET52321.6125
01:55 ET732621.73
01:57 ET319921.7
02:00 ET72521.67
02:02 ET110021.645
02:04 ET50021.59
02:06 ET70021.58
02:08 ET240021.65
02:09 ET85021.65
02:11 ET200021.615
02:15 ET40021.605
02:18 ET95321.61
02:20 ET40021.62
02:26 ET759121.7
02:27 ET175521.685
02:29 ET30021.68
02:31 ET203221.695
02:33 ET177521.67
02:36 ET40021.69
02:38 ET293521.675
02:40 ET50021.69
02:42 ET414421.645
02:44 ET85021.67
02:45 ET120021.61
02:47 ET184521.635
02:49 ET260121.64
02:51 ET172521.59
02:54 ET50021.59
02:58 ET280021.63
03:00 ET111621.615
03:02 ET1024921.61
03:03 ET195921.56
03:05 ET154621.55
03:07 ET424521.565
03:09 ET112521.53
03:12 ET284321.57
03:14 ET963021.61
03:16 ET902521.68
03:18 ET100021.68
03:20 ET272521.72
03:21 ET834421.71
03:23 ET922721.665
03:25 ET945121.685
03:27 ET360021.72
03:30 ET377221.75
03:32 ET619621.745
03:34 ET432321.725
03:36 ET521921.78
03:38 ET300421.77
03:39 ET120021.77
03:41 ET1620021.808
03:43 ET561721.83
03:45 ET141821.84
03:48 ET421221.915
03:50 ET1303221.945
03:52 ET1472522.059
03:54 ET1541121.99
03:56 ET2106822.18
03:57 ET1806122.135
03:59 ET27027622.18
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAKRO
Akero Therapeutics Inc
1.5B
-7.8x
---
United StatesEWTX
Edgewise Therapeutics Inc
1.5B
-10.4x
---
United StatesKURA
Kura Oncology Inc
1.5B
-9.4x
---
United StatesGYRE
Gyre Therapeutics Inc
1.4B
-0.8x
---
United StatesMORF
Morphic Holding Inc
1.4B
-8.2x
---
United StatesSYRE
Spyre Therapeutics Inc
1.4B
-0.5x
---
As of 2024-04-14

Company Information

Akero Therapeutics, Inc. is a clinical-stage company. The Company is developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH), a disease without any approved therapies. Efruxifermin (EFX), is its lead product candidate for MASH, which is being evaluated in the ongoing phase IIb SYMMETRY, phase III SYNCHRONY Histology, and phase III SYNCHRONY real-world studies. The phase III SYNCHRONY program builds on the results of two phase IIb clinical trials, the HARMONY study in patients with pre-cirrhotic MASH and the SYMMETRY study in patients with cirrhosis due to MASH. EFX is an analog of fibroblast growth factor 21 (FGF21), which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. EFX is designed to offer convenient once-weekly dosing.

Contact Information

Headquarters
601 Gateway Boulevard, Suite 350SOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-487-6488
Fax
302-655-5049

Executives

Independent Chairman of the Board
Mark Iwicki
President, Chief Executive Officer, Director
Andrew Cheng
Co-Founder, Chief Operating Officer, Executive Vice President, Secretary
Jonathan Young
Co-Founder, Chief Scientific Officer
Timothy Rolph
Chief Financial Officer, Executive Vice President, Head of Corporate Development, Treasurer
William White

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$0.00
Shares Outstanding
68.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.34
EPS
$-2.85
Book Value
$9.60
P/E Ratio
-7.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.